These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2222217)

  • 21. Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments.
    Maródi L; Casanova JL
    J Allergy Clin Immunol; 2010 Nov; 126(5):910-7. PubMed ID: 20943260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A patient with an immunodeficiency and consecutively 3 primary malignancies].
    Groot-Loonen JJ; Slater R; Taminiau J; Voûte PA
    Tijdschr Kindergeneeskd; 1989 Apr; 57(2):67-70. PubMed ID: 2662472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Simultaneous occurrence of transplantation glomerulopathy, malignant Hodgkin lymphoma and lip cancer in a patient under immunosuppressive treatment].
    Nemes B; Lázár N; Járay J
    Orv Hetil; 1994 Jun; 135(24):1309-12. PubMed ID: 8015827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Impaired immunologic reactivity as pacemaker for lymphoma development (author's transl)].
    Krüger G
    Verh Dtsch Ges Pathol; 1971; 55():200-4. PubMed ID: 4130717
    [No Abstract]   [Full Text] [Related]  

  • 25. Congenital immunodeficiencies and sepsis.
    Orange JS
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S99-S107. PubMed ID: 15857568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical immunology of immunodeficiency diseases symptoms and signs of primary immunodeficiencies.
    Aiuti F; Luzi G
    Ann Clin Res; 1987; 19(4):230-47. PubMed ID: 3314649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary immunodeficiency diseases and malignancy in Japan.
    Hayakawa H; Kobayashi N; Yata J
    Jpn J Cancer Res; 1986 Jan; 77(1):74-9. PubMed ID: 3082818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical course of malignant tumors of the otorhinolaryngeal organs in patients with immune deficiency].
    Iodov NN; Gerber VKh
    Vestn Otorinolaringol; 1985; (6):75-7. PubMed ID: 4090164
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical course and complications in Hodgkin's disease.
    Ultmann JE; Moran EM
    Arch Intern Med; 1973 Mar; 131(3):332-53. PubMed ID: 4347236
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunological deficiency syndromes, immunosuppression by drugs and occurrence of neoplasms: a casual association?].
    Dammacco F; Iodice G; Romagno D; Campobasso N
    Ric Clin Lab; 1985; 15 Suppl 2():11-23. PubMed ID: 4095454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Iatrogenic immunologic disorders and malignant tumors].
    Givel JC; Wauters JP; Chapuis G
    Helv Chir Acta; 1989 Dec; 56(4):425-30. PubMed ID: 2632465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recent findings in cellular immunodeficiency in lymphogranulomatosis].
    Müller G; Krüger W; Krug K; Hempel RD; Richter V; Rose H
    Radiobiol Radiother (Berl); 1983; 24(3):313-6. PubMed ID: 6635162
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunodeficiency and cancer: mechanisms involved.
    Cottier H; Hess MW; Wälti ER
    Schweiz Med Wochenschr; 1986 Aug; 116(34):1119-26. PubMed ID: 3532311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of the immunodeficient state in human pathology].
    Ivanovskaia TE
    Arkh Patol; 1983; 45(11):75-82. PubMed ID: 6670940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intersystem disintegration of immune protection functions in the pathogenesis of immunodeficiency states].
    Chernukh AM; Magaeva SV
    Fiziol Cheloveka; 1984; 10(2):202-10. PubMed ID: 6152428
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship of immunodeficiency to lymphoid malignancy.
    Kersey JH; Shapiro RS; Filipovich AH
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S10-2. PubMed ID: 2840629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant neoplasms in registered cases of primary immunodeficiency syndrome.
    Kobayashi N
    Jpn J Clin Oncol; 1985 Apr; 15 Suppl 1():307-12. PubMed ID: 4009992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Secondary immunologic deficiency and its correction in cancer patients after radiation and combined therapy].
    Filatov PP; Surinov BP
    Med Radiol (Mosk); 1987 Sep; 32(9):73-7. PubMed ID: 3498873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary immunodeficiencies: a field in its infancy.
    Casanova JL; Abel L
    Science; 2007 Aug; 317(5838):617-9. PubMed ID: 17673650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunodeficiency and Hodgkin's disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studies.
    Niehues T; Schellong G; Dörffel W; Bucsky P; Mann G; Körholz D; Göbel U
    Klin Padiatr; 2003; 215(6):315-20. PubMed ID: 14677095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.